We have 80 years experience in the field of complex and high value generic pharmaceutical products.


The safety and effectiveness of our pharmaceutical products are our symbol of quality.


Our production plant and quality control and development laboratories have the most advanced technologies.

Launch of new medicine for HIV

Laboratorios Richmond launches to the pharmaceutical market VIRONTAR N, the first Fixed-Dose Combination of Darunavir 800 mg and Ritonavir 100 mg in Argentina.

Read more +

Specialists discussed about the new drugs against HIV

El Dr. Cahn junto a Juan Manuel Artola, Marcelo Figueiras y Elvira Zini

On Thursday, August 6, Laboratorios Richmond sponsored together with Fundación Helios Salud and Fundación Huésped a Round Table in La Rural about the topic "What's new with the new drugs against the HIV virus?".

Issue of negotiable bonds

Emisión de obligaciones negociables

Laboratorios Richmond successfully placed negotiable bonds for $ 20 million, at an interest rate similar to that obtained by leading companies of the country. Among the main destinations of the subscribed capital it is to increase the productive capacity of the plant in Pilar.

Distinction in good environmental practices

Premiaron a Richmond

Tuesday July 7th, Laboratorios Richmond received the "Certificate of Recognition of Good Environmental Practices in Industry" from the municipality of Pilar.